The Great COVID Vaccine Bet
The CDC must decide whether to proceed with a new generation of vaccines that promise longer immunity. But many unknowns ...
What Really Happened In Wuhan?
A call for an independent investigation into the origins of COVID-19 renews interest in the virus's mutation patterns. It also ...
Summer of Healthcare
This summer promises to be tumultuous with many polarizing health issues coming to a head. The pending convergence provides an ...
Medicine & Law Cannot Get Along
Medicine and law have strained their relationship, butting heads on a host of issues of late. The problem lies in ...
How to Enforce Health Laws
In recent weeks, a slew of newly enacted health laws or revised interpretations emerged. Despite the changes, the means to ...
Are COVID Cases Really Rising?
We have seen an increase in COVID cases over the past weeks. The ensuing emotions expressed due to this rise ...
Addressing Developmental Delays in Pandemic Babies Lacking Social Interactions
It is hard to say if children who suffer from these delays can be caught up or if they will ...
The FDA Seeks to Ban Menthol Cigarettes
Some critics have raised concerns about potential unintended consequences of the proposed ban, particularly for African American menthol smokers.
US Task Force Recommends Anxiety Screening In Kids
Nearly 80% of chronic mental health conditions emerge in childhood, and when help is eventually sought, it is often years ...
Startup Innovation Meets DOJ Regulations
Marketing in healthcare has always been murky. For healthcare startups, it is downright dangerous, as it is where many Department ...
Medicare Advantage Versus Traditional Medicare
A report found most Medicare Advantage plans offer little value over traditional Medicare. We should now question the need for ...
What Quantum Mechanics Can Teach Healthcare
Observer effect is a bedrock principle in physics. By observing something, we change it. Interestingly, how we feel affects what ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more